Drawing for 3CP

USPTO serial 88904856

3CP

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
BUTLER, ANDREA P
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with 3CP?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jennifer Sheehan Anderson

Jennifer Sheehan Anderson BRIDGE INTELLECTUAL PROPERTY SERVICES PLLC143 CadyCenter, Suite 209Northville, MI 48167UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001pharmaceutical and veterinary preparations in the form of blood-based products being leukocyte, red blood cells, plasma, platelets, neutrophils, monocytes, white blood cells. macrophage, lymphocyte for use in manufacturing of a medicamentACTIVE—
005Pharmaceutical and veterinary preparations for the treatment of wounds, lesions and injuries; pharmaceutical and veterinary preparations, namely, pharmaceutical and veterinary preparations for the treatment of wounds, ulcers, lesions and injuries; pharmaceutical and veterinary preparations in the form of blood-based products leukocyte, red blood cells, plasma, platelets, neutrophils, monocytes, white blood cells. macrophage, lymphocyte for autologous use for the treatment of wounds, ulcers, lesions and injuries; pharmaceutical and veterinary preparations in the form of blood-based products, namely, leukocyte, red blood cells, plasma, platelets, neutrophils, monocytes, white blood cells, macrophage, lymphocyte for the treatment of wounds, ulcers, lesions and injuries; sanitary preparations for medical purposes; sanitary preparations for medical purposes, namely, sanitary sterilizing preparations for the treatment of wounds, lesions and injuries; dietetic preparations adapted for medical use; food for babies; material for stopping teeth; dental wax; disinfectants; preparations for destroying vermin; fungicides; herbicidesACTIVE—
007surgical, medical and veterinary apparatus and instruments being machines for manufacturing suture and wound closing materials and products; surgical, medical and veterinary apparatus and instruments being machines for manufacturing materials and products for the treatment of wounds, ulcers, lesions and injuriesACTIVE—
010Surgical, medical and veterinary apparatus and instruments, namely, apparatus for taking blood, autologous apparatus for collecting and processing blood used to create a wound covering or matrix to facilitate healing, blood component separation apparatus and instruments, blood filtering apparatus and instruments for medical purposes, coagulation instruments being a coagulation analyzer and a hemostasis analyzer; suture materials; artificial limbs, eyes and teeth; orthopedic articles, namely, surgical and medical apparatus and instruments for use in orthopedic surgery, walkers, cushions, shoes, supports, bandages, cooling patches for medical purposes, transdermal drug delivery patches sold without medication, drug delivery patches sold without medication, braces, splints, devices for diagnostic and therapeutic useACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jul 25, 2022MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 25, 2022ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Mar 21, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 21, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 21, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 24, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 22, 2021EX1GSOU EXTENSION 1 GRANTED—
Dec 22, 2021EXT1SOU EXTENSION 1 FILED—
Dec 22, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 22, 2021NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 27, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 27, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 7, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 19, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 19, 2021XAECEXAMINER'S AMENDMENT ENTERED—
Mar 19, 2021GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Mar 19, 2021GNEAEXAMINERS AMENDMENT E-MAILED—
Mar 19, 2021CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 19, 2021XAECEXAMINER'S AMENDMENT ENTERED—
Mar 19, 2021GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Mar 19, 2021GNEAEXAMINERS AMENDMENT E-MAILED—
Mar 19, 2021CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 17, 2021XAECEXAMINER'S AMENDMENT ENTERED—
Mar 17, 2021GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Mar 17, 2021GNEAEXAMINERS AMENDMENT E-MAILED—
Mar 17, 2021CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 9, 2021GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 9, 2021GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 9, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 5, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 5, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 5, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 7, 2020GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 7, 2020GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 7, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 4, 2020DOCKASSIGNED TO EXAMINER—
May 19, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 11, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance